Walleye Trading’s iShares Biotechnology ETF IBB Stock Holding History

Walleye Trading’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$405K	Sell	2,400 -600	-20%	-$103K	﹤0.01%	2714
2025 Q4	$506K	Sell	3,000 -8,800	-75%	-$1.43M	﹤0.01%	2814
2025 Q3	$1.7M	Buy	11,800 +3,300	+39%	+$450K	﹤0.01%	1917
2025 Q2	$1.08M	Buy	8,500 +2,500	+42%	+$307K	﹤0.01%	2151
2025 Q1	$767K	Sell	6,000 -30,000	-83%	-$4.07M	﹤0.01%	2230
2024 Q4	$4.76M	Buy	36,000 +20,400	+131%	+$2.87M	0.01%	1185
2024 Q3	$2.27M	Buy	15,600 +300	+2%	+$43.4K	﹤0.01%	1594
2024 Q2	$2.1M	Sell	15,300 -3,000	-16%	-$400K	0.01%	1575
2024 Q1	$2.51M	Sell	18,300 -59,100	-76%	-$8.07M	0.01%	1593
2023 Q4	$10.5M	Buy	77,400 +21,300	+38%	+$2.6M	0.02%	759
2023 Q3	$6.86M	Buy	56,100 +11,600	+26%	+$1.48M	0.02%	898
2023 Q2	$5.65M	Buy	44,500 +41,700	+1,489%	+$5.42M	0.02%	892
2023 Q1	$362K	Sell	2,800 -14,200	-84%	-$1.86M	﹤0.01%	3072
2022 Q4	$2.23M	Buy	17,000 +3,700	+28%	+$478K	0.01%	1596
2022 Q3	$1.56M	Sell	13,300 -29,800	-69%	-$3.7M	﹤0.01%	1898
2022 Q2	$5.07M	Buy	43,100 +34,300	+390%	+$4.07M	0.02%	1017
2022 Q1	$1.15M	Sell	8,800 -1,300	-13%	-$169K	﹤0.01%	2103
2021 Q4	$1.54M	Sell	10,100 -2,300	-19%	-$356K	0.01%	1860
2021 Q3	$2M	Buy	12,400 +1,600	+15%	+$269K	0.01%	1623
2021 Q2	$1.77M	Buy	10,800 +10,100	+1,443%	+$1.56M	0.01%	1603
2021 Q1	$105K	Sell	700 -3,200	-82%	-$508K	﹤0.01%	4066
2020 Q4	$591K	Buy	3,900 +3,100	+388%	+$443K	﹤0.01%	2509
2020 Q3	$108K	Sell	800 -1,200	-60%	-$163K	﹤0.01%	3368
2020 Q2	$273K	Buy	2,000 +400	+25%	+$51K	﹤0.01%	2826
2020 Q1	$172K	Sell	1,600 -4,900	-75%	-$564K	﹤0.01%	2733
2019 Q4	$783K	Sell	6,500 -900	-12%	-$100K	0.01%	2013
2019 Q3	$736K	Sell	7,400 -12,500	-63%	-$1.31M	0.01%	1829
2019 Q2	$2.17M	Buy	19,900 +2,900	+17%	+$308K	0.02%	988
2019 Q1	$1.9M	Sell	17,000 -8,700	-34%	-$954K	0.01%	1114
2018 Q4	$2.48M	Buy	25,700 +3,800	+17%	+$403K	0.02%	915
2018 Q3	$2.67M	Buy	21,900 +4,200	+24%	+$495K	0.01%	1066
2018 Q2	$1.94M	Buy	17,700 +5,400	+44%	+$578K	0.01%	1384
2018 Q1	$1.31M	Sell	12,300 -32,600	-73%	-$3.61M	0.01%	1656
2017 Q4	$4.8K	Sell	44,900 -6,400	-12%	-$684K	0.02%	693
2017 Q3	$5.7K	Sell	51,300 -37,500	-42%	-$4.01M	0.03%	581
2017 Q2	$9.18K	Buy	88,800 +67,500	+317%	+$6.65M	0.06%	328
2017 Q1	$2.08K	Sell	21,300 -37,800	-64%	-$3.62M	0.01%	1067
2016 Q4	$5.23M	Sell	59,100 -19,500	-25%	-$1.77M	0.04%	409
2016 Q3	$7.59M	Sell	78,600 -47,100	-37%	-$4.48M	0.05%	272
2016 Q2	$10.8M	Buy	125,700 +57,000	+83%	+$5.11M	0.07%	184
2016 Q1	$5.97M	Buy	68,700 +57,600	+519%	+$5.15M	0.05%	334
2015 Q4	$1.25M	Sell	11,100 -44,100	-80%	-$4.79M	0.01%	1076
2015 Q3	$5.58M	Buy	55,200 +21,000	+61%	+$2.52M	0.05%	274
2015 Q2	$4.21M	Sell	34,200 -4,500	-12%	-$539K	0.04%	388
2015 Q1	$4.43M	Buy	38,700 +5,100	+15%	+$562K	0.04%	354
2014 Q4	$3.4M	Buy	33,600 +6,900	+26%	+$671K	0.03%	436
2014 Q3	$2.43M	Buy	26,700 +5,400	+25%	+$474K	0.03%	351
2014 Q2	$1.82K	Sell	21,300 -29,700	-58%	-$2.34M	0.02%	451
2014 Q1	$4.02K	Sell	51,000 -6,000	-11%	-$500K	0.06%	200
2013 Q4	$4.32M	Buy	57,000 +21,600	+61%	+$1.53M	0.04%	331
2013 Q3	$2.48M	Buy	35,400 +34,800	+5,800%	+$2.28M	0.03%	467
2013 Q2	$35K	Buy	+600	New	+$34.7K	﹤0.01%	2359

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Walleye Trading's IBB Position: Q1 2026 in Review

Walleye Trading sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 31,184 shares — an estimated $5.33M sold.

Walleye Trading first reported a position in IBB in Q2 2013 and held it in 36 quarters. The position peaked at $5.26M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Walleye Trading reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Walleye Trading sold 31,184 iShares Biotechnology ETF shares in Q1 2026, an estimated $5.33M.
Walleye Trading first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 36 quarters.
Walleye Trading's iShares Biotechnology ETF position peaked at $5.26M in Q4 2025.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.